A Memphis-based device company has received a $4.6 million investment for its latest product. Ariste Medical has received the funding to continue development of a drug-eluting hernia mesh intended to reduce the risk of intra-abdominal infection. After hernia surgery, the risk of infection ranges from 8 percent to 40 percent, depending on complexity of the case.
UTRF News
UTRF Tech Talk: Protecting Your Ideas
The University of Tennessee Research Foundation (UTRF) presents: Protecting Your Ideas.
OPPORTUNITY NOW
Event Registration GET YOUR HEAD IN THE GAME! Do you have a great invention idea, but just don’t know what to do next? How do you turn your idea into a product? Are you certain that you even know who your audience really is? How do you go about reaching the right people to get (read more)